Analyser av MedCap

Analysbevakning

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

MedCap Q4 2024: A tale of euphoria and despair - Redeye

Redeye updates its estimates and valuation following MedCap releasing its Q4 2024 report.

Redeye • 03 Feb 07:19

MedCap Q4 2024: In line with profit warning, announces bolt-on deal - Redeye

Redeye provides its initial take on MedCap’s Q4 2024 report, which came in broadly below our initial estimates and in line with the company’...

Redeye • 31 Jan 10:07

MedCap: Preliminary Q4 figures significantly missed our estimates - Redeye

Redeye briefly comments on MedCap releasing preliminary Q4 2024 figures, significantly undershooting our estimates, especially at the EBITA ...

Redeye • 17 Jan 09:10

MedCap: In good health - Redeye

Redeye initiates coverage of MedCap, a serial acquirer of niche life science SMEs that has posted strong organic growth, acquired growth, an...

Redeye • 04 Nov 2024 07:28

Medcap: Abilia is back on track - Nordea

Medcap reported a better Q2 versus our estimates, attributable to a strong performance in the Medtech segment with Abilia showing a robust r...

Nordea • 02 Aug 2021 10:14